S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
NV
Recent Filings
- SC 13G/A61.0 KBSEELOS THERAPEUTICS, INC.Dec 4, 1:29 PM ET·0000929638-24-004157
- 8-K208.5 KBSEELOS THERAPEUTICS, INC.Nov 22, 8:35 AM ET·0001099910-24-000383
- SC 13G/A87.9 KBSEELOS THERAPEUTICS, INC.Nov 14, 7:32 PM ET·0000929638-24-003937
- SC 13G61.0 KBSEELOS THERAPEUTICS, INC.Nov 5, 1:46 PM ET·0000929638-24-003740
- 8-K227.7 KBSEELOS THERAPEUTICS, INC.Oct 24, 4:10 PM ET·0001104659-24-111155
- 8-K214.7 KBSEELOS THERAPEUTICS, INC.Oct 15, 9:15 AM ET·0001104659-24-108396
- 8-K205.0 KBSEELOS THERAPEUTICS, INC.Oct 7, 6:07 AM ET·0001104659-24-106406
- 8-K228.3 KBSEELOS THERAPEUTICS, INC.Sep 26, 4:10 PM ET·0001104659-24-103143
- 8-K1.0 MBSEELOS THERAPEUTICS, INC.Sep 25, 8:53 AM ET·0001104659-24-102625
- S-1559.2 KBSEELOS THERAPEUTICS, INC.Sep 25, 6:09 AM ET·0001104659-24-102540
Insiders
10- ARMISTICE CAPITAL, LLC10% Owner
- Berholtz RandyExecutive VP & General Counsel
- BERMAN RICHARD JDirector
- Boyd Steven10% Owner
- Cox Edward M.VP of Corp. Development and IR
- Crea RobertoDirector
- DALESANDRO MARGARETDirector
- Damaj BassamDirector, Chief Executive Officer
- DENNER ALEXANDER J10% Owner
- Dorsey BrianChief Development Officer
Tickers
No tickers on record
Addresses
business
300 PARK AVENUE 2ND FLOOR
NEW YORK, NY, 10022
mailing
300 PARK AVENUE 2ND FLOOR
NEW YORK, NY, 10022
Former Names
- APRICUS BIOSCIENCES, INC.2019-01-24
- NEXMED INC2010-09-13